Good Lifestyle

During the last year, Ozempic stormed the world. THE diabetes drug Quickly became one of the most notable people of weight weight, especially on the Hollywood scene, as celebrity treasure including Master of Chelsea And Elon Musk admitted to use it. But while some praised the way Ozempic quickly helped them lose weight, others recently presented horror stories on the medication. And now, the Food and Drug Administration of the United States (FDA) comes after some patients have cited "serious" gastrointestinal problems due to taking medication. Read the rest to find out why the FDA has just issued an ozempic update and what the agency recommends now.

In relation: Ozempic patients report a new debilitating side effect: "I want me to never touched it."

In the midst of Ozempic being announced by some as a miracle weight loss drug, other users began to share their experiences with a scary side effect last summer. Back in July, both Joanie Knight , a resident of Angie, in Louisiana, and Emily Wright , a teacher in Toronto, said to cnn Whether they were diagnosed with severe gastropares, whether their doctors think they had resulted or exacerbated by them by taking ozempic.

Gastroparesis, also known as the stomach paralysis, is a condition that slows down or completely stops the spontaneous movement of the muscles of your stomach The Mayo clinic . This can cause nausea constantly, vomiting and abdominal pain - all Knight and Wright said they had had trouble, even after taking the medication.

"I hope that I have never touched it. I hope that I have never heard of it about my life," Knight to CNN told "this medication made my hell. So much hell. cost me money. It cost me a lot of stress; it cost me days and nights and trips with my family. It cost me a lot, and it is not worth it. The price is too high. "

In relation: 5 things you need to know before taking Ozempic, according to a pharmacist .

Ozempic has become a popular drug loss because it contains semaglutide, which is a drug that works by imitating the natural GLP-1 hormone. While this hormone slows down food when it goes through the stomach, which helps reduce user appetites by making them feel full longer, problems can occur when it slows down digestion Also Many, according to CNN.

The potential link between semaglutide and gastropares is at the center of a recent trial against Novo Nordisk, the manufacturer of Ozempic, and Eli Lily and Co., which manufactures a similar weight loss medication called Mounjaro. Morgan and Morgan injury lawyer company filed the complaint August 2 in the name of Jaclyn Bjorklund , a 44-year-old woman who claims to have suffered from "severe gastrointestinal events" following the taking of Ozempic and Mounjaro, CNN reported.

Bjorklund has known "serious vomiting, stomach pain, gastrointestinal burn, hospitalization for stomach problems several times, including emergency visits, teeth falling due to excessive vomiting, requiring additional drugs to alleviate excessive vomiting and throw whole hours after eating, "according to the complaint .

The trial also claims that Novo Nordisk and Eli Lily "knew the association between the use of GLP-1 receptors and the risk of developing serious gastrointestinal problems, including gastropares and gastroenteritis" but failed to warn the users.

In relation: 4 foods that increase the same weight loss hormone as Ozempic, experts say .

Following reports of "serious" gastrointestinal problems such as gastropares, CNN Reports now That the FDA has decided to update the Ozempic label to recognize a specific gastrointestinal disorder: Ileus. According to the media, the labels of Mounjaro and another sister drug, Wegovy, have already recognized the reports of certain users developing this condition - and now the label of Ozempic has been updated to say the same thing. AE0FCC31AE342FD3A1346EBB1F342FCB

"Ileus is the term medical lack of movement somewhere in the intestines which leads to an accumulation and a potential blocking of food material", explains HRS On his website , noting that this condition is generally linked to gastropares. "An Ileus can lead to intestinal obstruction. This means that no food, gas or liquid material can pass."

In its update from September 22 to Ozempic drug label However, the FDA does not directly blame Ozempic or Novo Nordisk for users who develop Ileus. Instead, the agency simply recognizes that there have been reports from people with this gastrointestinal disorder following their use of the main medication used in ozempic.

"The following side effects were reported during the post-approval use of the semaglutide, the active ingredient of the Ozempic," said the update label. "Because these reactions are voluntarily reported with an uncertain population, it is not always possible to reliably estimate their frequency or to establish a causal relationship to exposure to drugs."

In a declaration of September 28, Novo Nordisk Recognized the update of the FDA At its label and explained that the company works in close collaboration with the FDA "to continuously monitor the safety profile" of its drugs, reported CBS News. "Novo Nordisk is held behind the safety and effectiveness of ozempic and all our drugs when used in accordance with product labeling and approved indications. For ozempic, the most common side effects Reported include: nausea, vomiting, diarrhea, stomach (abdominal) and constipation, "said the drug manufacturer.

For more health information sent directly to your reception box, Register for our daily newsletter .